{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:31:49Z","timestamp":1793385109497,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008667","name":"Senshin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07607"],"award-info":[{"award-number":["22K07607"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23591684"],"award-info":[{"award-number":["23591684"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K09813"],"award-info":[{"award-number":["15K09813"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jad.2026.122231","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:12:09Z","timestamp":1783699929000},"page":"122231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of baseline plasma NMDA receptor\u2013related amino acid ratios with remission following antidepressant treatment in major depressive disorder"],"prefix":"10.1016","volume":"414","author":[{"given":"Yuji","family":"Murase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Funatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiteru","family":"Takekita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-7272","authenticated-orcid":false,"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.122231_bb0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuroscience.2010.04.035","article-title":"Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex","volume":"169","author":"Ampuero","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2026.122231_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00804","article-title":"Chronic fluoxetine treatment induces maturation-compatible changes in the dendritic arbor and in synaptic responses in the auditory cortex","volume":"10","author":"Ampuero","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.122231_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.jad.2026.122231_bb0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/15622975.2022.2045354","article-title":"Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression","volume":"23","author":"Atake","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/mp.2017.61","article-title":"Neuronal plasticity and neurotrophic factors in drug responses","volume":"22","author":"Castr\u00e9n","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpsychires.2024.11.071","article-title":"Associations between social media use and positive mental health among adolescents: findings from the Canadian Health Behaviour in School-aged Children Study","volume":"181","author":"Clayborne","year":"2025","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122231_bb0040","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0045","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2026.122231_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1001\/archpsyc.1997.01830190015002","article-title":"A molecular and cellular theory of depression","volume":"54","author":"Duman","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/NMM:5:1:011","article-title":"Role of neurotrophic factors in the etiology and treatment of mood disorders","volume":"5","author":"Duman","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.jad.2026.122231_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.1222939","article-title":"Synaptic dysfunction in depression: potential therapeutic targets","volume":"338","author":"Duman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jad.2026.122231_bb0065","series-title":"An R Companion to Applied Regression","author":"Fox","year":"2019"},{"key":"10.1016\/j.jad.2026.122231_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000282","article-title":"Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum","volume":"4","author":"Gieger","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jad.2026.122231_bb0075","article-title":"Associations between relationship status and mental well-being in different life phases from young to middle adulthood","volume":"14","author":"Grundstr\u00f6m","year":"2021","journal-title":"SSM-Popul. Health"},{"key":"10.1016\/j.jad.2026.122231_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104127","article-title":"The non-adrenergic imidazoline-1 receptor protein nischarin is a key regulator of astrocyte glutamate uptake","volume":"25","author":"Gupta","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jad.2026.122231_bb0085","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","article-title":"How do antidepressants work? New perspectives for refining future treatment approaches","volume":"4","author":"Harmer","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.jad.2026.122231_bb0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00406-013-0399-y","article-title":"Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders","volume":"263","author":"Hashimoto","year":"2013","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0115","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1038\/tp.2016.8","article-title":"Abnormality in glutamine\u2013glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study","volume":"6","author":"Hashimoto","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1017\/neu.2015.59","article-title":"Increased serum levels of serine enantiomers in patients with depression","volume":"28","author":"Hashimoto","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jad.2026.122231_bb0125","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom. J."},{"key":"10.1016\/j.jad.2026.122231_bb0135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jad.2017.09.035","article-title":"Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity","volume":"226","author":"Ishiwata","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122231_bb0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpsychires.2017.02.003","article-title":"Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT","volume":"89","author":"Kato","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122231_bb0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.jad.2026.122231_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuint.2011.12.005","article-title":"GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine","volume":"60","author":"Kiss","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2026.122231_bb0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0006-3223(99)00284-X","article-title":"Increased cerebrospinal fluid glutamine levels in depressed patients","volume":"47","author":"Levine","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1460-9568.1998.00169.x","article-title":"Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons","volume":"10","author":"Li","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10571-007-9254-x","article-title":"BDNF level in the rat prefrontal cortex increases following chronic but not acute treatment with duloxetine, a dual acting inhibitor of noradrenaline and serotonin re-uptake","volume":"28","author":"Mannari","year":"2008","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.jad.2026.122231_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/1742-5573-4-4","article-title":"Power for tests of interaction: effect of raising the Type I error rate","volume":"4","author":"Marshall","year":"2007","journal-title":"Epidemiol. Perspect. Innov."},{"key":"10.1016\/j.jad.2026.122231_bb0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-014-3669-0","article-title":"D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression","volume":"232","author":"Moaddel","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jad.2026.122231_bb0185","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00125-017-4436-7","article-title":"Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study","volume":"61","author":"Molnos","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jad.2026.122231_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2022.07.001","article-title":"Personality as a basis for antidepressant selection for patients with depression: a two-point outcome study at 4 and 8 weeks","volume":"314","author":"Naito","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122231_bb0200","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2026.122231_bb0205","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40345-022-00274-4","article-title":"The course of psychiatric symptoms in older age bipolar disorder during the COVID-19 pandemic","volume":"10","author":"Orhan","year":"2022","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2026.122231_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2024.08.026","article-title":"Efficacy and safety of add-on sarcosine in patients with major depressive disorder: a randomized controlled trial","volume":"178","author":"Padhan","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.122231_bb0220","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2012.06.029","article-title":"Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists","volume":"150","author":"Papouin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jad.2026.122231_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2026.122231_bb0230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.119504","article-title":"Adjunctive d-serine treatment for major depressive disorder: a randomized clinical trial","volume":"387","author":"Sempach","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.122231_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/nu11071649","article-title":"Association between brain and plasma glutamine levels in healthy young subjects investigated by MRS and LC\/MS","volume":"11","author":"Takado","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.jad.2026.122231_bb0245","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00018-015-1937-8","article-title":"Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease","volume":"72","author":"Takahashi","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jad.2026.122231_bb0250","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrn2274","article-title":"Glutamate transporters: confining runaway excitation by shaping synaptic transmission","volume":"8","author":"Tzingounis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2026.122231_bb0255","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/s41598-017-05121-6","article-title":"Altered KYN\/TRP, Gln\/Glu, and Met\/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder","volume":"7","author":"Umehara","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2026.122231_bb0260","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jad.2026.122231_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006528.pub2","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2026.122231_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2017.10.008","article-title":"Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine","volume":"128","author":"Xu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2026.122231_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118458","article-title":"The significance of dysregulated serine metabolism in depression","volume":"191","author":"Yan","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jad.2026.122231_bb0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.jad.2026.122231_bb0285","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2010.06.016","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.122231_bb0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726010840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726010840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:48:47Z","timestamp":1793382527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726010840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S0165032726010840"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.122231","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of baseline plasma NMDA receptor\u2013related amino acid ratios with remission following antidepressant treatment in major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.122231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122231"}}